Market Research Blog – Page 3241 – New Product Development

Global Bot Services Market Thrives with US$ 1.2 Billion in 2021, Poised for 18% Growth by 2032

The current valuation of the worldwide bot services industry is US$ 1.6 billion, with a compound annual growth rate (CAGR) of 27.1% predicted to propel the market to US$ 18 billion by 2032.

The BFSI and e-Commerce industries use chatbots increasingly frequently. Businesses use chatbots for both customer support and internal work. Growing demand for feature phones combined with the use of cutting-edge NLP and AI technology is one of the factors driving the market for bot services. The globe has undergone a transformation due to urbanisation and digitalization, with bot services playing a key part. Additionally, efforts are being undertaken to standardise the ecosystem globally.

Various service companies did turn into bots during the pandemic, so as to help the clientele resolve issues without any propagation delay. The healthcare industry did see a spike in the sales of chatbots during the pandemic era. Several public healthcare and commercial websites made use of chatbots for diagnosing isolated patients and getting basic healthcare assessment done. On these grounds, the WHO, in April 2020, came up with chatbots on Fb messenger for providing precise information about Covid-19. Future Market Insights has walked through these facts with probable calls to action in its latest market study entitled ‘Bot Services Market’

Request a Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15670

Key Takeaways from Bot Services Market

North America holds the largest market share due to the US being home to hordes of IT companies.
Europe is at the matured stage in bot services market and expected to show this consistency in the upcoming period.
The Asia-Pacific, led by India, Japan, and China, is expected to be the fastest growing region in bot services market in the near future.

Competitive Landscape

Microsoft Corporation, in January 2021, did announce transitioning Microsoft healthcare Bot Service to ‘Azure’ to enable customers to take an advantage of the latter’s improved tools, compliance, and security features.
Poynter Institute’s IFCN (International Fact-Checking Network), in May 2020, came up with Whatsapp-enabled chatbots for providing access to translated network comprising over 80 fact-checking organizations across the globe.
Alvaria, in June 2022, put forth its very first native product called ‘Alvaria CX Suite’, which comes across as combination of Noble Contact Center and Unified IP/Advanced List Management from Aspect. CX suite has been rounded out with self-service, omnichannel, fraud detection capabilities, and compliant outreach.
Meta, in February 2022, launched the latest innovation regarding Universal Speech Translator, wherein it would be extending support to languages sans standard writing system (both – spoken and written).
Baidu, in November 2021, tabled PLATO-XL. It’s an AI model meant for dialogue generation. At present, it does outperform existing commercial chatbots on several conversational benchmarks, thereby showing exceptional performance.
Mindsay, in April 2021, used Genesys App Foundry for publishing AI chatbots. The agents are likely to quickly leave and engage in conversations with the customers through chatbot interface by integration of Mindsay chatbots with Genesys Cloud, that too, day in day out.
Yellow Messengers, an AI chat bot firm, did receive US$ 20 Mn in April 2020 from an investor for fulfiling the growing need of the market.

“With internet penetration witnessing an exponentiation, the global bot services market is likely to grow inadvertently in the forecast period”, says an analyst from Future Market Insights.

What are the inclusions of Bot Services Market Report?

Future Market Insights offers an exclusive perspective and various real-time insights on the bot services market in its latest study, presenting historical demand assessment of 2016 – 2021 and projections for 2022 – 2032.
The research study is based on service (platform and framework), by mode of channel (website, contact centers, social media, and mobile applications), by business function (sales & marketing, human resource, finance, supply chain & logistics, and IT), by application (customer engagement & retention, workforce management, agent performance management, content management, appointment scheduling, employee on-boarding, and others), by deployment mode (on-premises and cloud), by organization size (SMEs and large enterprises), and by vertical (BFSI, retail & e-Commerce, healthcare & life sciences, media & entertainment, travel & hospitality, IT telecom, government, and other verticals).
Bots let users add various intelligent agents communicating without investment of money and time in incorporating AI of their own.

Browse Full Report:
https://www.futuremarketinsights.com/reports/bot-services-market

Bot Services Market Segmentation

By Service:

Framework
Platform

By Mode of Channel:

Website
Contact Centers
Social Media
Mobile Applications

By Business Function:

Sales & Marketing
Human Resource (HR)
Finance
Supply Chain & Logistics
Information Technology (IT)

By Application:

Customer Engagement & Retention
Workforce Management
Agent Performance Management
Content Management
Appointment Scheduling
Employee On boarding
Other Applications

By Deployment Mode:

On-premises
Cloud

Organization Size:

Large Enterprises
SMEs

Verticals:

BFSI
Retail & e-commerce
Healthcare & Life Sciences
Media & Entertainment
Travel & Hospitality
IT & Telecom
Government
Other Verticals

By Region:

North America
Latin America
Europe
APAC
MEA

Ask An Analyst :
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15670

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

United State and Canada Biosimulation Industry is predicted to grow at a CAGR of 21.6% to reach US$8.7 Billion by 2032 | FMI Study

The favorable government policies in the United States, as well as growing healthcare expenditures due to the prevalence of chronic illnesses, are major drivers driving drug research and discovery in the United States and Canada. The Biosimulation Industry in the United States is expected to reach US$8.7 billion by 2032.

With an estimated market size of US$ 2.6 billion in 2021, the global biosimulation industry is expected to develop at an astounding rate of 21.5% CAGR over the following ten years. The market is expected to reach a whopping US$ 20.9 billion by the end of 2032, driven by the urgent need for the creation of novel medications to tackle the global rise in various diseases.

The most recent market analysis study emphasizes how crucial biosimulation software is to maintaining this extraordinary development trajectory. The results indicate that the software sector will account for a significant amount of revenue in the biosimulation industry. Using biosimulation software is essential to improving trial efficiency and yielding better, more precise findings.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-16031

Report Attributes	Details
Estimated Market Value (2022E)	US$ 3.1 Billion
Forecasted Market Value (2032F)	US$ 20.9 Billion
Global Market Growth Rate (2022 to 2032)	21.5% CAGR
United States Growth Rate (2022 to 2032)	~21.6% CAGR

North America holds the largest market for biosimulation. The rising chronic disease among the population in the region and regulations implemented by the governments for patient safety and treatment standards is driving the demand for biosimulation in the region

Revenue through Drug Development to Continue Growth Axis For Global Biosimulation Industry

Pharmaceutical companies use biosimulation for drug development. During a drug, development process biosimulation helps to identify the possible effects that the drug can have on a patient. The market through the drug development segment recorded a CAGR of 16.3% during 2015-2021.

Global Biosimulation Industry: Competition Insights

Certara
Dassault Systemes
Advanced Chemistry Development
Simulation Plus Inc
Schrodinger, Inc.
Chemical Computing Group
Physiomics Plc
Rosa & Co. LLC
BioSimulation Consulting Inc.
Genedata AG
Instem Group of Companies
PPD, Inc.
Insilico Biotechnology AG
Rhenovia Pharma
LeadInvent Technologies
Nuventra Pharma
In Silico Biosciences

Buy The Full Report Now!
https://www.futuremarketinsights.com/checkout/16031

Some of the recent developments by key providers of biosimulation are as follows:

In June 2022, Certara announced its new version of Biosimulation software for the progress of Novel Biologics. The new version includes Immunogenicity (IG), Immuno-Oncology (IO), and Vaccine simulators to understand and predict how drugs work and point out the key questions in the development of novel biologic therapies.
In June 2022, Genedata AG announced that Syros Pharmaceuticals has chosen Genedata AG’s Genedata Profiler as its data integration and investigative platform to accelerate its translational research strategy.
In March 2022, Advanced Chemistry labs announced that Pharmaron Inc. has chosen its NMR processing and interpretation software.
In March 2022, Simulation Plus, Inc. released its Membrane Plus 3.0 software. The new software includes improved data handling and simulation performance for in vitro-in vivo for extrapolation (IVIVE) for permeability, skin penetration, and release assay systems.
In February 2022, the US Food and Drug Administration (FDA) approved the license for Certara’s Immunogenicity (IG) stimulator to research and assess immunogenicity in protein-based remedies.
In February 2022, Physiomics Plc updated a new agreement with ValiRx plc. According to the new agreement, ValiRx will be able to use Physiomics Plc’s latest version of its Virtual Tumour technology. Physiomics Plc will also help ValiRx in modeling the use of VAL201 peptide in endometriosis (VAL301) and Coronavirus (BC201).

Key Segments Covered in Global Biosimulation Industry Survey

Biosimulation Market by Product Type:

Services
- In-house services
- Contract services
Software

Biosimulation Market by Deployment Mode:

Drug Development
Drug Discovery
Other Applications

Biosimulation Market by End-use:

Pharmaceutical &Biotechnology Companies
CROs
Regulatory Authorities
Academic Research Instituitons

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Extracorporeal CO2 Removal Devices Industry is expected to reach US$ 170.9 Million by 2032 at a 5.8% CAGR | FMI

The world’s foremost source of market research and advisory services, Future Market Insights (FMI), has released an extensive industry study report on the Global Extracorporeal CO2 Removal Devices Industry. The market is expected to develop significantly, according to the analysis, with worldwide sales expected to reach US$ 91.6 million in 2021 and a projected worth of US$ 170.9 million by 2032. This indicates a strong Compound Annual Growth Rate (CAGR) of 5.8% between 2022 and 2032.

The comprehensive analysis conducted by FMI includes insights into market data about more than 5000 medications in more than 100 countries. This abundance of data is a great tool for learning about the extracorporeal CO2 removal devices market’s present and potential futures. The study offers a thorough examination, providing details on well-known performers and new entrants in the medical industry.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15994

Over the past decade, the healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancements in technology have created impressive scope within the medical sector for diagnostics and therapeutics.

The report offers extensive data sets validating key trends impacting growth in the Extracorporeal CO2 Removal Devices industry. It offers insights into strategies adopted by the key players and addresses the concerns that will challenge the growth of the Extracorporeal CO2 Removal Devices industry. With our extensive research and information about the past, current, and future market scenario, the Extracorporeal CO2 Removal Devices market report will help and identify the concerns, for a smooth sail of small & medium as well as large enterprises.

Recent developments in the Global Extracorporeal CO2 Removal Devices Industry include:

In December 2018, ALung Technologies made significant progress in clinical trial programs for the Hemolung Respiratory Assist System (RAS). This device plays a crucial role in the extracorporeal CO2 removal process.
In September 2017, the Hemolung Respiratory Assist Device (RAS) received Investigational Device Exemption (IDE) approval to conduct VENT-AVOID trials of the system.
Other recent developments related to companies offering extracorporeal CO2 removal devices have been tracked by the team at Future Market Insights and are available in the full report.

Critical Questions Answered in the Report
What are ongoing trends that will shape the market growth curve for the global Extracorporeal CO2 Removal Devices industry?
What are the drivers and challenges affecting the Extracorporeal CO2 Removal Devices industry demand?
What are the recent technological advancements in the Extracorporeal CO2 Removal Devices industry?
What are key trends and opportunities that will prevail in the revenue growth of Extracorporeal CO2 Removal Devices industry players?
How will evolving regulatory policies impact market growth?
What is the impact of COVID-19 on the Extracorporeal CO2 Removal Devices industry?

Why Future Market Insights?
Comprehensive analysis of evolving purchase patterns across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the Extracorporeal CO2 Removal Devices industry
Detailed information about the product innovation, mergers, and acquisitions lined up in upcoming years
Ground-breaking research and market player-centric solutions for the upcoming decade according to the present market scenario category, with a CAGR of 6.2% between 2022 and 2032.

Get Ahead with Comprehensive Information – Purchase Today!
https://www.futuremarketinsights.com/checkout/15994

Global Extracorporeal CO2 Removal Devices Industry: Segmentation

Market Segments Covered in Extracorporeal CO2 Removal Devices Industry Analysis

By Product Type:

Extracorporeal CO2 Machines
Disposables
Other Product Types

By Application Type:

Acute Respiratory Distress Syndrome (ARDS)
Chronic Obstructive Pulmonary Disease (COPD)
Bridge to Lung Transplant
Other Applications

By Sample Type:

Venovenous
Arteriovenous

Comprehensive analysis of the regional markets offers exclusive insights into the market performance across geographies along with relevant graphs, figures, and a list of tables.

By Region

North America
Europe
Latin America
Asia Pacific
META

Detailed analysis of the geographical region and country-wise insights are offered in the latest Extracorporeal CO2 Removal Devices market report with established market players as well as incumbents in the region.

Competitive Analysis

By Prominent Global Extracorporeal CO2 Removal Devices Industry Players

Medtronic
Getinge AB
Xenios AG
Along Technologies
ESTOR S.P.A
Medical Spa
Aferectica Srl

With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects, and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the Extracorporeal CO2 Removal Devices market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

United Kingdom Hair Restoration Industry is expected to grow at an impressive 14.7% annual rate and reach US$ 657 Million by 2032 | FMI

The United Kingdom Hair Restoration Industry is anticipated to develop at a 14.7% CAGR from 2022 to 2032, reaching US$ 5.8 billion. Between 2022 and 2032, the market is projected to provide an absolute dollar potential of US$ 657 million.

Future Market Insights (FMI) predicts that the Global Hair Restoration Industry will see a significant shift, with revenues expected to reach US$ 4.9 billion in 2021. A strong growth trajectory is revealed in the most recent comprehensive research from FMI, which projects an astounding Compound Annual Growth Rate (CAGR) of 18.2% from 2022 to 2032. By the end of 2032, the industry is expected to have a significant worth of US$ 30.8 billion based on this trend.

The remarkable growth prospect is supported by a confluence of variables driving market expansion. The industry’s profitability is mostly driven by the rising incidence of alopecia, rising worldwide disposable income, and changing lifestyles. In addition, the impressive success rates of hair transplant operations and the continuous advancements in technology for minimally invasive hair replacement techniques significantly contribute to the market’s upward trajectory.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15964

The market is gaining pace as the success rate of therapies such as Follicular Unit Extraction (FUE) and Follicular Unit Transplantation (FUT) has grown and proven to be viable options for hair restoration.

Furthermore, many hair stylists now blend these two treatments for the best aesthetic results. One of the key reasons for their popularity is that hair restoration methods have become less invasive in recent years. The MEA region can be projected to be the most lucrative region in this market during the forecast period, 2022- 2032.

Global Hair Restoration Industry Competitive Analysis

The Global Hair Restoration Industry’s vibrant competition stems from the increasing number of brands offering cutting-edge technology in hair restoration. These brands are continuously enhancing features to deliver the optimal consumer experience while maintaining affordability across various income brackets. Additionally, the growing e-commerce sector further fuels market growth. Key industry players including Bernstein Medical, Milla Marie, Cole Hair Transplant Group, Lexington Intl., and Bosley are at the forefront of this dynamic landscape.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-15964

Recent noteworthy developments by key Hair Restoration providers include:

May 2019 Milestone: Both Hair Club and Bosley unveiled their groundbreaking product, BioGraft. This remarkable innovation represents a fusion of meticulous and non-surgical hair restoration techniques. The introduction of BioGraft significantly expanded the companies’ hair relocation product portfolios. These industry leaders are deeply committed to Research and Development to pioneer technologically advanced products.
February 2018 Acquisition: In a significant move, Venus Concept announced the acquisition of NeoGraft Solutions’ hair restoration business. NeoGraft was known for its pioneering technology and topical products in the hair restoration field.

Top Key Companies Profiled in the Global Hair Restoration Industry:

Bernstein Medical
Bosley
Harley Street Clinic
Advanced Hair Studio
Milla Marie
Lexington Intl., LLC
Venus Concept
Cole Hair Transplant Group

Click here today to buy your full report
https://www.futuremarketinsights.com/checkout/15964

Some of the recent developments of key Global Hair Restoration providers are as follows:

In May 2019, Hair Club and Bosley both reported the delivery of BioGraft. For a great change, the development enhancement combines meticulous and nonsurgical hair rebuilding. This new item shipment aided in the expansion of the company’s hair relocation product portfolio. The company invests heavily in R&D to develop mechanically advanced products.
In February 2018, Venus Concept announced the acquisition of NeoGraft Solutions’ hair restoration business. Neograft was a hair restoration technology and topical product developer.

Segments Covered in Global Hair Restoration Industry Analysis

By Procedure Type:

Follicular Unit Extraction
Follicular Unit Transplantation

By Therapy Type:

Low-Level Laser Therapy (LLLT)
Stem Cell Hair Restoration
Platelet-Rich Plasma

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pharmaceutical Dissolution Testing Services Industry is expected to surpass US$ 1538.48 Million by 2033, With an 8.3% CAGR | FMI

Pharmaceutical Dissolution Testing Services Market

Forecasts indicate that the Global Pharmaceutical Dissolution Testing Services Industry globally is expected to develop significantly, rising from US$ 693.12 million in 2023 to an astounding US$ 1,538.48 million by 2033. This significant growth is a result of a strong Compound Annual Growth Rate (CAGR) of 8.3% throughout the projected period, which indicates that the pharmaceutical industry’s need for dissolution testing services is expanding.

The need for enhanced dissolution testing services is driven by increased pharmaceutical research endeavors, which are the foundation of the market value growth. The market saw a consistent compound annual growth rate (CAGR) of 5.2% in the years leading up to 2022, which set the stage for the faster growth expected in the next ten years.

Leading the charge in comprehensive market analysis is Future Market Insights (FMI), offering unparalleled insights sourced from the foremost pharmaceutical and healthcare device manufacturers worldwide. With access to data encompassing over 5000+ drugs across more than 100 countries, FMI provides a panoramic view of the current and future landscape of the Pharmaceutical Dissolution Testing Services Market.

Request a Sample of this Report Now!
https://www.futureMarketinsights.com/reports/sample/rep-gb-15959

The report offers extensive data sets validating key trends impacting growth in the Pharmaceutical Dissolution Testing Services Market. It offers insights into strategies adopted by the key players and addresses the concerns that will challenge the growth of the Pharmaceutical Dissolution Testing Services Market. With our extensive research and information about the past, current, and future Market scenario, the Pharmaceutical Dissolution Testing Services Market report will help and identify the concerns, for a smooth sail of small & medium as well as large enterprises.

Critical Questions Answered in the Report

What are ongoing trends that will shape the market growth curve for the Global Pharmaceutical Dissolution Testing Services Industry?
What are the drivers and challenges affecting the Pharmaceutical Dissolution Testing Services Market demand?
What are the recent technological advancements in the Pharmaceutical Dissolution Testing Services Market?
What are key trends and opportunities that will prevail in the revenue growth of Pharmaceutical Dissolution Testing Services Market players?
How will evolving regulatory policies impact the Market growth?
What is the impact of COVID-19 on the Pharmaceutical Dissolution Testing Services Market?

Ask Us Your Questions About This Report
https://www.futureMarketinsights.com/ask-the-analyst/rep-gb-15959

Global Pharmaceutical Dissolution Testing Services Industry: Segmentation

By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Detailed analysis of the geographical region and country-wise insights are offered in the latest Pharmaceutical Dissolution Testing Services Market report with established market players as well as incumbents in the region.

By Segment:

Method
Dosage Form
Dissolution Apparatus
Region

Comprehensive analysis of the regional Markets offers exclusive insights on the Market performance across geographies along with relevant graphs, figures, and list of tables.

Competitive Analysis

By Prominent Global Pharmaceutical Dissolution Testing Services Industry Players

Intertek Group Plc.
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermo Fisher Scientific Inc.
Cambrex
Charles River Laboratories
Boston Analytical

With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and Marketing strategy adopted by these players in the Pharmaceutical Dissolution Testing Services Market

Buy a Complete Research Report
https://www.futureMarketinsights.com/checkout/15959

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of Market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the Pharmaceutical Dissolution Testing Services Market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and Market player-centric solutions for the upcoming decade according to the present Market scenario

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Arterial Cannula Industry Is Expected to Reach US$40 Billion by 2033 at a 6.6% CAGR | FMI

Positive predictions for the Global Arterial Cannula Industry were revealed by a ground-breaking study conducted by Future Market Insights (FMI). The study projects an outstanding compound annual growth rate (CAGR) of 6.6% from 2023 to 2033. After ten years of study, the market is expected to be valued at an astounding US$40 billion, indicating the start of a new phase of medical technology innovation and progress.

The rise in the need for arterial cannulas is ascribed to the increasing prevalence of chronic illnesses that require urgent medical attention. Modern medical treatments are needed since procedures like dialysis, cardiopulmonary bypass surgery (CABG), and extracorporeal membrane oxygenation (ECMO) are becoming more common. The global arterial cannula market is expected to be essential in supplying this expansion, propelling itself into an era of unparalleled growth.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15945

The increased incidence of lifestyle disorders like obesity and diabetes is increasing the number of surgical procedures performed throughout the world. This is a significant factor that is expected to improve arterial cannula market sales. Moreover, the growing aging population and rising demand for minimally invasive procedures (MIS) are likely to propel market growth. The worldwide Global Arterial Cannula Industry is predicted to increase at an exponential rate during the forecast period, owing primarily to the rising prevalence of cardiovascular illnesses. According to the American Heart Association, approximately half of all individuals in the United States had some kind of cardiovascular disease in 2019. Furthermore, according to the CDC, around 20.1 million persons aged 20 and older in the United States had coronary artery disease in 2020, accounting for approximately 7.2% of the overall population.

Furthermore, the rising popularity of aesthetic operations, as well as the expanding influence of social media, is driving up demand for arterial cannulas. In Addition to that, good government laws for delivering essential healthcare services, as well as advances in healthcare facilities are expected to drive the Global Arterial Cannula Industry. Furthermore, important suppliers are investing in R&D projects to create high-quality items.

Key Takeaways from the Global Arterial Cannula Industry Study

FMI projects the Global Arterial Cannula Industry to expand at a 6.6% value CAGR by 2033
The global arterial cannula market is estimated at a market value of US$ 21 Billion
The Global Arterial Cannula Industry is expected to garner a market value of US$ 40 Billion
North America is expected to be the most lucrative for arterial cannula market growth
As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 6.1% in the assessment period 2023-2033.
As per Future Market Insights, Europe is expected to grow at a CAGR of 6.3% in the assessment period 2023-2033.
The hospital segment is expected to hold the largest market share for arterial cannulas in the forecast period 2023-2033.

“Asian countries with large ageing populations, such as Japan, China, and India, promises significant development potential for the sector in this area,” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Ask Us Your Questions About This Report
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15945

Global Arterial Cannula Industry Competition:

Medtronic, plc.
LivaNova plc
Edward Lifesciences
Getinge AB
Fresenius Medical Care
BD, Nipro Corp.
Andocor
Freelife Medical GmbH
Surgical Holdings
Kangxin Medical.

Global Arterial Cannula Industry Recent Developments:

In April 2020, LivaNova Plc. got a CE mark for their Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula for ECMO treatments in which femoral artery cannulation can be used.

More Insights Available

In its new offering, Future Market Insights presents an unbiased analysis of the Global Arterial Cannula Industry, presenting historical analysis from 2018 to 2022 and forecast statistics for 2023-2033.

The study reveals essential insights based on Application (ECMO, Cardiopulmonary Bypass Surgery), by Size (20-22 Fr, 35-36 Fr), by End-use (Hospitals, ASCs), across five major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Grab Your Report on Discount Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-15945

Key Segments Profiled in the Global Arterial Cannula Industry Survey

Global Arterial Cannula Industry by Application:

Extracorporeal Membrane Oxygenation (ECMO)
Cardiopulmonary Bypass Surgery
Others

Global Arterial Cannula Industry by Size:

14-16 Fr
17-19 Fr
20-22 Fr
23-25 Fr
26-28 Fr
29-31 Fr
32-34 Fr
35-36 Fr

Global Arterial Cannula Industry by End Use:

Hospitals
Ambulatory Surgical Centers
Others

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global 3D Printed Prosthetics Industry is predicted to grow at an 8% annual rate and reach US$3.5 Billion by 2033 | FMI

From 2023 to 2033, the Global 3D Printed Prosthetics Industry is expected to rise at a strong Compound Annual Growth Rate (CAGR) of 8%, according to FMI Insights’ analysis. The sector is reaching previously unheard-of heights due to a rise in healthcare spending, technological improvements in 3D printing, and a spike in demand for customized prostheses.

By 2033, the market should have achieved a significant milestone—valuing itself at US$3.5 billion. Because of its strong healthcare infrastructure and high adoption rates, North America is expected to have a dominant share of the market. A growing knowledge of cutting-edge prosthetic solutions and better healthcare facilities are expected to drive Asia-Pacific’s quick growth.

Leading the charge in this transformative industry are key players such as 3D Systems, Stratasys, and Materialise, among others. These industry giants are at the forefront of innovation, driving the adoption of 3D-printed prosthetics globally.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15940

COVID-19’s introduction had an impact on the additive manufacturing sector, as the pandemic created supply chain bottlenecks and manufacturing closures, particularly in the first three quarters of 2020. The 3D printing market, on the other hand, saw a huge surge in the aftermath of the pandemic since it is a disruptive technology that has emerged as a viable solution to medical device supply constraints. Furthermore, the market’s top players reported a sales growth in 2021, showing that the market has recovered from the impact of COVID-19 and is likely to grow fast in the future.

Key Takeaways from the Global 3D Printed Prosthetics Industry Study

The limbs category is expected to account for 35% of total revenue in the worldwide 3D Printed Prosthetics market.
The hospitals category is expected to account for up to 40% of overall revenue in 2023 in terms of end use.
Polypropylene, by material, is expected to dominate the global market in 2023, accounting for 33% of total revenue.
In 2023, North America is expected to dominate the global market, accounting for more than 40% of global revenue.
Asia Pacific is expected to account for 37% of the market for 3D printed prostheses by 2023.

“Increasing cases of accidental and sports injures is the key factor driving the growth of the Global 3D Printed Prosthetics Industry. In addition, technological advancement too is spurring the adoption of 3D Printed Prosthetics,” comments a Future Market Insights analyst.

Request Methodology Now!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15940

Global 3D Printed Prosthetics Industry Competitive Landscape

Some of the players in the Global 3D Printed Prosthetics Industry include 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Bionicohand, YouBionic, UNYQ, Mecuris, LimbForge, Inc., Open Bionics, Create Prosthetics, Bio3D Technologies, Laser GmbH, Prodways Group, Protosthetics, 3T RPD Ltd, Formlabs

YouBionic, a key player in 3D Printed Prosthetics is focusing on making their 3D printed prosthetic hand durable, flexible and more movable. Thus, the company is integrating artificial intelligence to increase its usability.
Prodways Group, another key player in the 3D Printed Prosthetics market offers a technologically advanced arm for patients of all age groups. The company is focusing on offering the same to a wider consumer base by penetrating into different geographical locations.

More Valuable Insights

In its new offering, Future Market Insights presents an unbiased analysis of the Global 3D Printed Prosthetics Industry, presenting historical analysis from 2018 to 2022 and forecast statistics for 2023 to 2033.

Top 16 Key Companies Profiled In the Global 3D Printed Prosthetics Industry

3D Systems Corporation
EnvisionTEC
Stratasys Ltd.
Bionic hand
YouBionic
UNYQ
Mecuris
LimbForge, Inc.
Open Bionics
Create Prosthetics
Bio3D Technologies
C Laser GmbH
Prodways Group
Prosthetics
3T RPD Ltd.
Formlab

Click Here To Buy Your Full Report!
https://www.futuremarketinsights.com/checkout/15940

Key Segments Profiled in the Global 3D Printed Prosthetics Industry Survey

Type:

Sockets
Limbs
Joints
Others

Material:

Polyethylene
Polypropylene
Acrylics
Polyurethane

End-use:

Hospitals
Rehabilitation Centres
Prosthetic Clinics

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Surgical Retractors Industry is expected to reach US$ 4.1 Billion by 2032, exhibiting a 8% CAGR | FMI

Based on a thorough market assessment by Future Market Insights (FMI), the Global Surgical Retractors Industry, estimated to be worth US$ 1.8 billion in 2021, is expected to grow at a remarkable rate, hitting US$ 4.1 billion by 2032. According to the research, the neurosurgical application has a notable Compound Annual Growth Rate (CAGR) of 10.7% in sales.

A rising focus on neurology applications is likely to increase demand for improved surgical retractors since neurosurgical operations play a crucial role in treating a range of neurological illnesses. The World Federation of Neurology reports that around 12% of all neurology patients pass away from these illnesses each year. This information is clarified in the study. This concerning figure highlights how urgent it is to improve surgical methods and tools to improve patient outcomes.

Surgery is the single and primary form of treatment for neurological conditions. The increase in neurological surgeries and the high demand for surgical retractors manufactured especially for these procedures are the main reasons why the neurosurgery segment dominates the market for surgical retractors.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15931

The United States will hold the largest share of the market throughout the Analysis Period

From 2022 to 2032, the Surgical Retractors Market is estimated to develop at a CAGR of 8.9% in the United States; taking the market to US$ 1.1 Bn by 2032. From 4% of GDP in the 1960s to 19.7% of GDP in 2020, the US’s healthcare costs have grown significantly.

Chronic renal illness affects 15% of Americans, according to the Centers for Disease Control and Prevention. The rising prevalence of chronic diseases is therefore predicted to increase the need for surgical intervention, which will raise demand for surgical retractors and generate an absolute dollar growth potential of US$ 663 Mn.

Global Surgical Retractors Industry: Competition Insights

The key companies operating in the Surgical Retractors Market include Baxter International Inc., B. Braun Melsungen AG, The Cooper Companies, Inc., Terumo Corporation, Teleflex Incorporated, Medtronic Plc., Medline Industries INC., Johnson & Johnson, NOVO NORDISK, Integra Lifesciences Holdings Corporation, HENKE-SASS WOLF, Henry Schein, Inc., Dickinson and Company, Conmed Corporation, SKLAR Surgical Instruments., Teleflex Incorporated., Olympus Corporation, Thompson Surgical, Arthrex, Inc., Microsurgical Technology, STRYKER CORPORATION, GLOBUS MEDICAL, Applied Medical Resources Corporation, Innomed, Inc., LiNA Medical ApS, Vivo Surgical Private Limited, and Changzhou Haiers Medical Devices Co. Ltd.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15931

Some of the recent developments by key providers of the Global Surgical Retractors Industry are as follows:

In April 2021, to connect its StealthStation S8 surgical navigation system with Surgical Theater’s SyncAR augmented reality (AR) technology, Medtronic plc established a cooperation with the company. Through this partnership, neurosurgeons will be able to use augmented reality (AR) technology in real time to improve visualization during challenging cranial surgeries.
In March 2020, a collaboration between JUNE MEDICAL and Vivo Surgical was established that led to the Galaxy II LUX self-retaining ring retractor with light. The Galaxy II retractor offered by June Medical and the KLARO light provided by Vivo Surgical, which has a specially made clip for it, are combined to create this gadget. By giving surgeons better access to and a clearer vision of the surgical site, this retractor has the advantage of removing the drawbacks of employing overhead lighting or personal head torches.
In May 2019, ONETRAC LX, a newly created single-use cordless surgical retractor that is outfitted with a multi-LED light source and dual smoke evacuation channels, was introduced by OBP, one of the top makers of self-contained and single-use medical devices. The newly created surgical retractor provides operating surgeons and nurses with the best possible smoke clearance capabilities.

Buy a Complete Research Report
https://www.futuremarketinsights.com/checkout/15931

Key Segments Covered in Global Surgical Retractors Industry Survey

By Application:

Handheld
Self-retaining

By Product Type:

Abdominal retractor
Finger retractor
Nerve Retractor
Orthopedic Retractor
Rectal Retractor
Thoracic retractor
Ribbon retractor
Other Product Types

By Application Size:

Neurosurgery
Wound closure
Reconstructive surgery
Cardiovascular
Orthopedic
Obstetrics and Gynecology (Ob/Gyn)
Other Applications

By End-use:

Hospitals
Ambulatory Surgical Centers
Clinics

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Malaria Treatment Industry will reach US$ 2.93 Billion, growing at a projected 5% CAGR from 2023 to 2033 | FMI

The Global Malaria Treatment Industry is expected to rise at an unprecedented rate, with a projected market value of US$ 1.80 billion in 2023, up from US$ 1.72 billion in 2022, according to a ground-breaking discovery. These findings, which were made public by a thorough analysis published by Future Market Findings (FMI), provide insight into the market’s potential trajectory from 2023 to 2033. The report projects a stunning 5% Compound Annual Growth Rate (CAGR) and a whopping US$ 2.93 billion by the end of 2033.

With over 210 million cases of malaria worldwide in 2019, the World Intellectual Property Organisation (WIPO) has emphasized the disease’s continued importance and potential for fatality. Plasmodium, a tiny parasite spread to people via mosquito bites, is the cause of the illness. Among the four plasmodium species responsible for malaria, plasmodium falciparum is identified as the primary contributor to fatal cases.

Due to increased funding from regional governments, the global market for anti-malaria drugs is likewise growing rapidly. This money ought to make it feasible for research companies like Medicines for Malaria Venture to keep looking at potential lead chemicals that might combat malaria. For instance, in November 2017, the US Agency for International Development (USAID) gave US$ 9 million to Medicines for Malaria Venture to be used for three projects: a pharmacovigilance study of Pyramax (pyronaridine-artesunate), a SERC Phase III research to establish a single-exposure revolutionary cure, and a study to evaluate the efficacy of DSM265, a prospective single-exposure radical cure. These improvements are anticipated to drive the global market for malaria therapy.

Request a Sample of Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15905

Region-wise, the MEA will grow with the fastest CAGR during the forecast period. The Middle East and Africa have held the lion’s share of the market share and are expected to continue doing so in the future due to the fast-rising incidence of malaria in the region. According to the World Health Organization (WHO) report 2021, 241 million cases of malaria were anticipated worldwide in 2020, with 228 million of those cases happening in the WHO African Region. As a result, one of the largest segments of the market for anti-malarial medications is expected to come from the Middle East and Africa. Such developments will bolster the growth from 2023-2033.

Key Takeaways from the Global Malaria Treatment Industry Study

The global malaria treatment market is currently worth more than US$ 1.72 Billion.
The oral segment by route of administration is going to occupy a 49% global market share in 2023.
The hospital pharmacies segment by distribution channel type will be the fastest-growing segment during the forecast period with a 5.4% CAGR.
The North American region is predicted to grow with a steady CAGR of 4.6% during 2023-2033.
The MEA malaria treatment market is expected to grow with a steady CAGR of 5.5% during 2023-2033.

Contact our Market Research Specialist:
https://www.futuremarketinsights.com/ask-question/rep-gb-15905

“Some of the factors driving the market for malaria therapy include the incidence of malarial infection, government initiatives and awareness-raising campaigns, the availability of anti-malarial drugs, and rising healthcare expenditures.” comments a Future Market Insights analyst.

Global Malaria Treatment Industry Competitive Landscape

Zydus Healthcare Ltd., Sun Pharmaceutical Industries Ltd., Sanofi SA, GSK Plc, Novartis AG, Cipla Ltd, Viatris Inc., Lupin Ltd, Advacare Pharma USA Llc, and VLP Therapeutics LLC are a few of the well-known companies in the worldwide market for treating malaria.

The Gates Foundation-funded Gavi immunization program introduced the GlaxoSmithKline (GSK) Mosquirix vaccine in three African countries—Kenya, Ghana, and Malawi—in July 2022. The first antimalarial vaccine ever created is allegedly this one. In countries with moderate to high P. falciparum malaria transmission rates, this is an essential initial step in the malaria vaccine deployment.
In March 2022, Tafenoquine, a brand-new drug that cures a particular strain of malaria, received a license in Australia from Medicines for Malaria Venture (MMV), which also co-developed the drug with GlaxoSmithKline (GSK) for use in children and teenagers. The drug is coupled with chloroquine, a popular anti-malarial drug.

Buy This Report:
https://www.futuremarketinsights.com/checkout/15905

Key Segments Covered in the Global Malaria Treatment Industry Report

Global Malaria Treatment Industry by Treatment:

Prescription Medications
Vaccines
Diagnostic Tests
Others

Global Malaria Treatment Industry by Drug Type:

Branded
Generic

Global Malaria Treatment Industry by Route of Administration:

Oral and Parenteral
Intravenous

Global Malaria Treatment Industry by Distribution Channel:

Direct Tender
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Global Malaria Treatment Industry by End User:

Hospitals
Specialty Clinics
Homecare
Others

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Vulvovaginal Candidiasis Treatment Industry is expected to grow at a 4.5% CAGR and reach a valuation of US$ 1.607 Billion by 2033 | According to FMI

The Global Vulvovaginal Candidiasis Treatment Industry estimated to be worth an astounding US$ 1.035 billion in 2023, is poised for significant change, with a predicted Compound Annual Growth Rate (CAGR) of 4.5%. The healthcare industry’s technical breakthroughs are responsible for this amazing growth, which is expected to drive the market to a projected value of US$ 1.607 billion by 2033.

A serious health concern is the rise in the incidence of vulvovaginal candidiasis, which is a result of an increase in diabetes cases and frequent antibiotic usage among people. Because more research and development efforts are being made in tandem to get accurate diagnoses, it is anticipated that the increase in VVC instances will spur market expansion.

Request a Sample Report Now to get Premium Insights:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15875

The rapid increase in the global disease burden, coupled with escalating demand for better treatment options and an increasing number of hospital-acquired infections, is also propelling the demand for bacterial vulvovaginal candidiasis treatment.

Furthermore, expanding healthcare infrastructure in developing economies, availability of pharmaceutical drugs, and robust technological advancements in the biopharmaceutical industries are all contributing to significant opportunities for vulvovaginal candidiasis treatment over the forecasted period.

Key Takeaways from the Global Vulvovaginal Candidiasis Treatment Industry Study

As of 2023, the vulvovaginal candidiasis treatment industry was valued at US$ 1035 Million
From 2023 to 2033, the industry is poised to grow at a 4.5% CAGR
By 2033, the vulvovaginal candidiasis treatment market is slated to reach a valuation of US$ 1607 Million
By route of administration, the oral segment accounted for the largest share of 43.2% and is expected to continue this trend over the forecast period.
China is poised to yield a CAGR of 4.2% to vulvovaginal candidiasis treatment in 2033

“Increasing prevalence of VVC cases and technological advancement in healthcare are expected to radically transform the vulvovaginal candidiasis treatment industry in the coming years,” comments an analyst at FMI.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15875

Global Vulvovaginal Candidiasis Treatment Industry Competitive Landscape

Astellas Pharma Inc., Mycovia Pharmaceuticals, Inc., Basilea Pharmaceutica Ltd., Scynexis, Inc., Grupo Ferrer Internacional S.A., Pfizer, Inc., Cadila Pharmaceuticals, Bayer AG., Bristol-Myers Squibb Company are some of the key companies in the vulvovaginal candidiasis treatment market.

These players are continuously adopting various strategies such as new product launches, facility expansions, mergers, collaborations, partnerships, and acquisitions to increase their revenue share and gain a competitive edge in the market. for instance,

In October 2022 – Astellas Pharma Inc. and Pantherna Therapeutics GmbH announced that the companies have entered into a new technology evaluation agreement for research to generate mRNA-based regenerative medicine programs using direct reprogramming (transdifferentiation)*.

In August 2022 – Mycovia Pharmaceuticals, Inc. announced that it will present VIVJOA™ (oteseconazole) capsules in patients with recurrent vulvovaginal candidiasis (RVVC) at the 2022 Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting. VIVJOA is the first and only FDA-approved medication for RVVC indicated to reduce the incidence of RVVC in females with a history of RVVC who are NOT of reproductive potential
In July 2022 – Mycovia Pharmaceuticals, Inc. announced the U.S. availability of VIVJOA™ (oteseconazole) capsules, an azole antifungal indicated to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential.

Key Segments Covered in the Global Vulvovaginal Candidiasis Treatment Industry Industry Survey

Global Vulvovaginal Candidiasis Treatment Industry by Drug Class:

Clotrimazole
Nystatin
Fluconazole
Ketoconazole
Terbinafine
Terconazole
Others

Global Vulvovaginal Candidiasis Treatment Industry by Route of Administration:

Oral Vulvovaginal Candidiasis Treatment
Intravenous Vulvovaginal Candidiasis Treatment
Topical Vulvovaginal Candidiasis Treatment

Global Vulvovaginal Candidiasis Treatment Industry by Distribution Channel:

Hospital Pharmacy for Vulvovaginal Candidiasis Treatment
Retail Pharmacy for Vulvovaginal Candidiasis Treatment
Online Pharmacy for Vulvovaginal Candidiasis Treatment

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/15875

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube